Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine/Naloxone for Opiate Dependence
NCT00000353Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Oct 1996
- Primary completion
- Sep 1997
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine, naloxone in opioid use disorder (OUD), sponsored by National Institute on Drug Abuse. Started Oct 1996; status: completed.
02
Drugs
buprenorphinenaloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00000353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000353.